| |
|
|
|
Oasmia Pharmaceutical AB (publ)  
|
|
4.14 -0.12 (-0.03%) |
10-19 16:00 |
|
Open: |
4.25 |
Pre close: |
4.26 |
Target:
|
6.66
|
|
High: |
4.3085 |
Low: |
4.14 |
Resistance:
|
5.70
6.66
|
|
Volume: |
15,220 |
Market Cap: |
256M |
Support:
|
3.70
 2.46
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.04
 |
MACD |
MACD(12,26):
|
0.32 |
|
MA(20): |
4.10 |
Signal(12,26,9): |
0.39 |
|
MA(100): |
2.21 |
Stochastic Oscillator |
%K(14,3):
|
48.75 |
|
MA(250): |
1.63 |
%D(3): |
38.53 |
|
Average Volume(K) |
3-Month: |
7555
|
52-Week |
High:
|
5.70 |
|
10-Days: |
5826 |
Low: |
0.80 |
|
RSI |
RSI(14):
|
57.04 |
Change(%): |
398.8 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-32.3 |
Shares Out. (M) |
59.77 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-20.2 |
Shares Float (M) |
59.77 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
15.9 |
% Held by Institutions |
0.10 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
185 |
|
Book Value (p.s.) |
2.630 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.57 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-11.55 |
P/S |
37117169664.00 |
|
Operating Margin |
-813.76 |
Levered Free Cash Flow
(M) |
-14.19 |
P/CF |
-21.42 |
|
|
|
|
|
|
